- About CDC
- Diseases & Conditions
- Programs & Campaigns
-
Data & Statistics
- Taiwan National Infectious Disease Statistics System
- Statistics of HIV/AIDS
- Disease Surveillance Express
- Influenza Express
- National Notifiable Disease Surveillance Report
- Weekly Report of Enterovirus Infection
- School-based Surveillance Report
- Taiwan Healthcare-associated infection and Antimicrobial resistance Surveillance System
- Taiwan CDC Open Data Portal
- International Cooperation
| Title | PublishTime |
|---|---|
| COVID-19蛋白質次單元疫苗與mRNA疫苗於真實世界中重症與死亡保護效益相似，已刊載於美國CDC官方期刊《新興傳染病》（Emerging Infectious Diseases） | 2024/2/2 |
| 疾管署嚴正澄清：疫苗所含鋁鹽佐劑安全無虞，請民眾勿相信錯誤資訊 | 2024/1/3 |
| 因應預防接種受害救濟基金總額低於法定下限，調整兩種疫苗徵收金額 | 2023/12/29 |
| 疾管署再次說明有關緊急採購不良家用快篩試劑處理方式 | 2023/10/18 |
| 疾管署說明有關緊急採購家用快篩試劑相關疑義 | 2023/10/17 |
| 為提升民眾免疫保護力，10月2日起分三階段擴大65歲以上民眾公費接種肺炎鏈球菌疫苗 | 2023/9/8 |
:::
About CDC
Data & Statistics
- Taiwan National Infectious Disease Statistics System
- Statistics of HIV/AIDS
- Disease Surveillance Express
- Influenza Express
- National Notifiable Disease Surveillance Report
- Weekly Report of Enterovirus Infection
- School-based Surveillance Report
- Taiwan Healthcare-associated infection and Antimicrobial resistance Surveillance System
- Taiwan CDC Open Data Portal
Taiwan Centers for Disease Control
TEL：886-2-2395-9825
Copyright © 2024 Taiwan Centers for Disease Control. All rights reserved.